Enhanced Control of Hypertension and Thrombolysis Stroke Study (STAY ENCHANTED)

Wardlaw, Joanna (Principal Investigator)

Status	Finished
Effective start/end date	1/04/16 → 1/10/18

Funding

Other: £79,547.00

1 Article

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): An international randomised, open-label, blinded-endpoint phase 3 trial
ENCHANTED Investigators and Coordinators, Anderson, C. S., Huang, Y., Lindley, R. I., Chen, X., Arima, H., Chen, G., Li, Q., Billot, L., Delcourt, C., Bath, P. M., Broderick, J. P., Demchuk, A. M., Donnan, G. A., Durham, A. C., Lavados, P. M., Lee, T. H., Levi, C., Martins, SO., Olavarria, V. V., & 15 othersPandian, J. D., Parsons, M. W., Pontes-Neto, O. M., Ricci, S., Sato, S., Sharma, V. K., Silva, F., Song, L., Thang, NH., Wardlaw, J. M., Wang, J-G., Wang, X., Woodward, M., Chalmers, J. & Robinson, T. G., 2 Mar 2019, In: The Lancet. 393, 10174, p. 877-888 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File